# Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation

> **NCT01024491** · PHASE3 · COMPLETED · sponsor: **MorePharma Corporation** · enrollment: 174 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** paroxetine
- **DRUG:** paroxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01024491
- **Lead sponsor:** MorePharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-03
- **Final completion:** 2009-04
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2009-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01024491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01024491, "Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01024491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*